RenataDHA:RENATA +0.74%85 Days Inventory is 208.24 as of Mar. 2026, which is 33% above its 10-year median of 157.13. GuruFocus rates DHA:RENATA with a GF Score™ of 85/100 and a GF Value™ of BDT812.71 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 923 Drug Manufacturers companies, Renata ranks worse than 62.3% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Renata's Average Total Inventories for the
three
months ended in Mar. 2026 was BDT14,273 Mil. Renata's Cost of Goods Sold for the
three
months ended in Mar. 2026 was BDT6,254 Mil.
Hence, Renata's Days Inventory for the
three
months ended in Mar. 2026 was 208.24.
The historical rank and industry rank for Renata's Days Inventory or its related term are showing as below:
DHA:RENATA'
s Days Inventory Range Over the Past 10 Years
Min: 130.17 Med: 157.13 Max: 198.35
Current: 196
During the past 13 years, Renata's highest Days Inventory was 198.35. The lowest was 130.17. And the median was 157.13.
DHA:RENATA's Days Inventory is ranked worse than 62.3% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs DHA:RENATA: 196.00
Renata's Days Inventory
declined
from Mar. 2025 (222.47) to Mar. 2026 (208.24).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Renata's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Renata's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.25.
Renata (DHA:RENATA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Renata's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Renata's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Renata Days Inventory Related Terms
Renata Days Inventory Historical Data
* Premium members only.
The historical data trend for Renata's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:RENATA vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Renata's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Renata Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Renata's Days Inventory distribution charts can be found below:
* The bar in red indicates where Renata's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Renata (DHA:RENATA) has a Days Inventory of 208.24 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Renata and its competitors. This is 33% above median its historical median of 157.13. Over the past decade, Renata's Days Inventory has ranged from 130.17 to 198.35. According to the industry distribution chart, Renata ranks #575 out of 923 companies in the Drug Manufacturers industry, placing it in the top 62.3%.
Is Renata's Days Inventory too high?
Renata's current Days Inventory of 208.24 is 33% above median its 10-year median of 157.13. Over the past 10 years, this metric has ranged from a low of 130.17 to a high of 198.35. The Drug Manufacturers industry median Days Inventory is 164.48. Renata's value of 208.24 is 26.6% above this industry median. Based on the distribution chart, Renata ranks #575 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Renata has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Renata's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Renata ranks #575 out of 923 companies for Days Inventory. This places Renata in the lower half of its industry. The industry median Days Inventory is 164.48. Renata's value of 208.24 is 26.6% above this benchmark. Historically, Renata's own Days Inventory has ranged from 130.17 to 198.35 over the past decade. While the company's 10-year median is 157.13 vs. the industry median of 164.48, Renata has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Renata's current Days Inventory of 208.24 is 26.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Renata and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Renata's current Days Inventory is 208.24, which is 33% above median its own 10-year median of 157.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Renata stock overvalued right now?
Based on GuruFocus' analysis, Renata (DHA:RENATA) is currently considered Significantly Undervalued. The stock's GF Value™ is BDT812.71, compared to a current price of BDT463.90 — trading 42.9% below its estimated fair value. The current Days Inventory is 208.24, which is 33% above median its 10-year median of 157.13 and 26.6% above the Drug Manufacturers industry median of 164.48. Renata's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Renata (DHA:RENATA), the current Days Inventory is 208.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Renata (DHA:RENATA) Overvalued in 2026?
Based on GuruFocus' analysis, Renata stock appears to be undervalued.
The current stock price of BDT463.90 is trading 42.9% below its estimated GF Value™ of BDT812.71.
GuruFocus considers Renata to be Significantly Undervalued.
Key valuation signals for DHA:RENATA:
Days Inventory: 208.24 (33% above median its 10-year median of 157.13)
GF Value™: BDT812.71 vs. price of BDT463.90 (42.9% below fair value)
Industry Position: 26.6% above the Drug Manufacturers median (#575 of 923)
No single metric tells the full story. See the DHA:RENATA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Renata PLC is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.
85GF Score
Get the complete analysis for DHA:RENATA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:RENATA has been successfully added to your 
